NCR Graphs - Age Specific Incidence Rates

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 1200IU, Blood Coagulation Factor VIII - 500IU		Injectable lyophilised powder for solution+diluent	L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 2mg	2mg (100KIU)	Injectable powder for solution+diluent	105,957,406 L.L
B02BD08	ARYOSEVEN RT	BioTech	Eptacog alfa - 1mg	1mg	Injectable powder for solution+diluent	16,902,713 L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 1mg	1mg (50KIU)	Injectable powder for solution+diluent	57,890,287 L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 5mg	5mg (250KIU)	Injectable powder for solution+diluent	264,894,762 L.L
B02BD08	RECOFACT VII	BioTech	Eptacog alfa (activated) recombinant - 1.2mg	1.2mg	Injectable powder for solution+diluent	47,533,131 L.L
B02BD08	ARYOSEVEN RT	BioTech	Eptacog alfa - 1mg	1mg	Injectable powder for solution+diluent	L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 1mg	1mg (50KIU)	Injectable powder for solution+diluent	L.L
B02BX01	DICYNONE	B	Etamsylate - 250mg/2ml	250mg	Injectable solution	482,439 L.L
B02BX01	DICYNONE	B	Etamsylate - 500mg	500mg	Capsule	1,311,590 L.L
B02BX04	NPLATE	BioTech	Romiplostim - 250mcg	250mcg	Injectable powder for solution	67,369,332 L.L
B02BX04	NPLATE	BioTech	Romiplostim - 250mcg	250mcg	Injectable powder for solution	L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 25mg	25mg	Tablet, film coated	79,847,895 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 50mg	50mg	Tablet, film coated	67,227,846 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 50mg	50mg	Tablet, film coated	L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 60mg/0.4ml	60mg/0.4ml	Injectable solution	441,042,377 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 30mg/ml	30mg/ml	Injectable solution	224,585,721 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 150mg/ml	150mg/ml	Injectable solution	716,437,779 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 105mg/0.7ml	105mg/0.7ml	Injectable solution	577,741,643 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 30mg/ml	30mg/ml	Injectable solution	L.L
B03AA02	FERRATE	G	Ferrous fumarate - 20mg/ml (iron element)	20mg/ml	Suspension	533,505 L.L
B03AA02	FEOSTA	G	Ferrous fumarate - 200mg	200mg	Tablet, film coated	682,160 L.L
B03AA02	FEOSTA	G	Ferrous fumarate - 200mg	200mg	Tablet, film coated	9,355,300 L.L
B03AA07	PEDIAFER	G	Ferrous (sulfate) - 15mg/ml	15mg/ml	Drops	388,370 L.L
B03AA07	TIMOFEROL	G	Iron bivalent (as dried ferrous sulfate) - 50mg (172.73mg), Ascorbic acid - 30mg		Capsule	652,931 L.L
B03AB	ENRICH N	G	Iron trivalent (hydroxide polymaltose complex) - 156.25mg/5ml		Syrup	279,519 L.L
B03AB05	ENRICH N	G	Iron trivalent (hydroxide polymaltose complex) - 50mg/ml	50mg/ml	Drops	459,594 L.L
B03AB09	FERPLEX	B	Iron trivalent (ferric proteinsuccinylate) - 800mg	800mg	Solution	1,202,739 L.L
B03AC	VENOFER I.V.	B	Iron (sucrose) - 100mg/5ml	100mg/5ml	Injectable concentrated solution	3,594,779 L.L
B03AC	FER PANPHARMA	G	Iron (sucrose) - 100mg/5ml	100mg/5ml	Injectable solution	2,315,441 L.L

رسومات بيانية لسجل الوطني للسرطان - نسب الحدوث حسب العمر والموقع